Diagnostics firm secures €2m for blood test for pregnant women

20th May, 2018
Clockwise from left: Frank Walsh, partner, Enterprise Equity; Bill Liao, European investment partner, SOSventures; Charles Garvey, chief executive, Metabolomic Diagnostics; and Professor Louise Kenny, consultant obstetrician at CUMH and director of the INFANT Centre with four-day-old baby Molly

Company: Metabolomic Diagnostics

Done Deal:€2 million EU funding

The clincher:“We plan to market the product next year, and with this support from EU, we believe that PrePsia has the potential to become part of pregnancy screening programmes worldwide” - Charles Garvey, chief executive, Metabolomic Diagnostics

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Tom Maguire: Tax changes we make now could help business for years

More Business Tom Maguire 10 months ago

The Daily Briefing

The Daily Briefing